Literature DB >> 25597763

Changes in the metabolism of sphingolipids after subarachnoid hemorrhage.

Fernando D Testai1, Hao-Liang Xu, John Kilkus, Vidyani Suryadevara, Irina Gorshkova, Evgeny Berdyshev, Dale A Pelligrino, Glyn Dawson.   

Abstract

We previously described how ceramide (Cer), a mediator of cell death, increases in the cerebrospinal fluid (CSF) of subarachnoid hemorrhage (SAH) patients. This study investigates the alterations of biochemical pathways involved in Cer homeostasis in SAH. Cer, dihydroceramide (DHC), sphingosine-1-phosphate (S1P), and the activities of acid sphingomyelinase (ASMase), neutral sphingomyelinase (NSMase), sphingomyelinase synthase (SMS), S1P-lyase, and glucosylceramide synthase (GCS) were determined in the CSF of SAH subjects and in brain homogenate of SAH rats. Compared with controls (n = 8), SAH patients (n = 26) had higher ASMase activity (10.0 ± 3.5 IF/µl· min vs. 15.0 ± 4.6 IF/µl • min; P = 0.009) and elevated levels of Cer (11.4 ± 8.8 pmol/ml vs. 33.3 ± 48.3 pmol/ml; P = 0.001) and DHC (1.3 ± 1.1 pmol/ml vs. 3.8 ± 3.4 pmol/ml; P = 0.001) in the CSF. The activities of GCS, NSMase, and SMS in the CSF were undetectable. Brain homogenates from SAH animals had increased ASMase activity (control: 9.7 ± 1.2 IF/µg • min; SAH: 16.8 ± 1.6 IF/µg • min; P < 0.05) and Cer levels (control: 3,422 ± 26 fmol/nmol of total lipid P; SAH: 7,073 ± 2,467 fmol/nmol of total lipid P; P < 0.05) compared with controls. In addition, SAH was associated with a reduction of 60% in S1P levels, a 40% increase in S1P-lyase activity, and a twofold increase in the activity of GCS. In comparison, NSMase and SMS activities were similar to controls and SMS activities similar to controls. In conclusion, our results show an activation of ASMase, S1P-lyase, and GCS resulting in a shift in the production of protective (S1P) in favor of deleterious (Cer) sphingolipids after SAH. Additional studies are needed to determine the effect of modulators of the pathways described here in SAH.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  cerebrovascular disorders; sphingolipids; subarachnoid hemorrhage

Mesh:

Substances:

Year:  2015        PMID: 25597763      PMCID: PMC4359096          DOI: 10.1002/jnr.23542

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  59 in total

1.  FK506 prevents stroke-induced generation of ceramide and apoptosis signaling.

Authors:  I Herr; A Martin-Villalba; E Kurz; P Roncaioli; J Schenkel; M G Cifone; K M Debatin
Journal:  Brain Res       Date:  1999-05-01       Impact factor: 3.252

2.  Fingolimod provides long-term protection in rodent models of cerebral ischemia.

Authors:  Ying Wei; Muge Yemisci; Hyung-Hwan Kim; Lai Ming Yung; Hwa Kyoung Shin; Seo-Kyoung Hwang; Shuzhen Guo; Tao Qin; Nafiseh Alsharif; Volker Brinkmann; James K Liao; Eng H Lo; Christian Waeber
Journal:  Ann Neurol       Date:  2010-11-12       Impact factor: 10.422

3.  DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells.

Authors:  Teka-Ann S Haynes; Valery Filippov; Maria Filippova; Jun Yang; Kangling Zhang; Penelope J Duerksen-Hughes
Journal:  Biochim Biophys Acta       Date:  2012-02-11

4.  Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling.

Authors:  Monowarul M Siddique; Ying Li; Liping Wang; Jianhong Ching; Mainak Mal; Olga Ilkayeva; Ya Jun Wu; Boon Huat Bay; Scott A Summers
Journal:  Mol Cell Biol       Date:  2013-04-01       Impact factor: 4.272

5.  Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells.

Authors:  Vineet Gupta; Kaustubh N Bhinge; Salman B Hosain; Katherine Xiong; Xin Gu; Runhua Shi; Ming-Yi Ho; Kay-Hooi Khoo; Su-Chen Li; Yu-Teh Li; Suresh V Ambudkar; S Michal Jazwinski; Yong-Yu Liu
Journal:  J Biol Chem       Date:  2012-08-30       Impact factor: 5.157

6.  Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia.

Authors:  Waltraud Pfeilschifter; Bożena Czech-Zechmeister; Marian Sujak; Ana Mirceska; Alexander Koch; Abdelhaq Rami; Helmuth Steinmetz; Christian Foerch; Andrea Huwiler; Josef Pfeilschifter
Journal:  Biochem Biophys Res Commun       Date:  2011-08-22       Impact factor: 3.575

7.  Differential expression patterns of gangliosides in the ischemic cerebral cortex produced by middle cerebral artery occlusion.

Authors:  Dong Hoon Kwak; Sung Min Kim; Dea Hoon Lee; Ji Su Kim; Sun Mi Kim; Seo Ul Lee; Kyu Yong Jung; Byoung Boo Seo; Young Kug Choo
Journal:  Mol Cells       Date:  2005-12-31       Impact factor: 5.034

8.  Differential regulation of sphingomyelin synthesis and catabolism in oligodendrocytes and neurons.

Authors:  John P Kilkus; Rajendra Goswami; Sylvia A Dawson; Fernando D Testai; Eugeny V Berdyshev; Xianlin Han; Glyn Dawson
Journal:  J Neurochem       Date:  2008-06-28       Impact factor: 5.372

9.  Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.

Authors:  Michelle M Mielke; Walter Maetzler; Norman J Haughey; Veera V R Bandaru; Rodolfo Savica; Christian Deuschle; Thomas Gasser; Ann-Kathrin Hauser; Susanne Gräber-Sultan; Erwin Schleicher; Daniela Berg; Inga Liepelt-Scarfone
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

10.  Imaging mass spectrometry detection of gangliosides species in the mouse brain following transient focal cerebral ischemia and long-term recovery.

Authors:  Shawn N Whitehead; Kenneth H N Chan; Sandhya Gangaraju; Jacqueline Slinn; Jianjun Li; Sheng T Hou
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

View more
  10 in total

1.  A facile stable-isotope dilution method for determination of sphingosine phosphate lyase activity.

Authors:  Jung H Suh; Abeer Eltanawy; Apoorva Rangan; Julie D Saba
Journal:  Chem Phys Lipids       Date:  2015-09-25       Impact factor: 3.329

Review 2.  The role of dihydrosphingolipids in disease.

Authors:  Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang
Journal:  Cell Mol Life Sci       Date:  2018-12-06       Impact factor: 9.261

3.  Sphingosine-1-phosphate, a novel TREM2 ligand, promotes microglial phagocytosis to protect against ischemic brain injury.

Authors:  Tengfei Xue; Juan Ji; Yuqin Sun; Xinxin Huang; Zhenyu Cai; Jin Yang; Wei Guo; Ruobing Guo; Hong Cheng; Xiulan Sun
Journal:  Acta Pharm Sin B       Date:  2021-10-22       Impact factor: 14.903

Review 4.  Critical Role of the Sphingolipid Pathway in Stroke: a Review of Current Utility and Potential Therapeutic Targets.

Authors:  Na Sun; Richard F Keep; Ya Hua; Guohua Xi
Journal:  Transl Stroke Res       Date:  2016-06-24       Impact factor: 6.829

5.  Role of Lysocardiolipin Acyltransferase in Cigarette Smoke-Induced Lung Epithelial Cell Mitochondrial ROS, Mitochondrial Dynamics, and Apoptosis.

Authors:  Mounica Bandela; Vidyani Suryadevara; Panfeng Fu; Sekhar P Reddy; Kamesh Bikkavilli; Long Shuang Huang; Sugasini Dhavamani; Papasani V Subbaiah; Sunit Singla; Steven M Dudek; Lorraine B Ware; Ramaswamy Ramchandran; Viswanathan Natarajan
Journal:  Cell Biochem Biophys       Date:  2021-11-01       Impact factor: 2.989

6.  Metabolic basis of neuronal vulnerability to ischemia; an in vivo untargeted metabolomics approach.

Authors:  Sherif Rashad; Daisuke Saigusa; Takahiro Yamazaki; Yotaro Matsumoto; Yoshihisa Tomioka; Ritsumi Saito; Akira Uruno; Kuniyasu Niizuma; Masayuki Yamamoto; Teiji Tominaga
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

7.  Sphingosine 1-phosphate levels in cerebrospinal fluid after subarachnoid hemorrhage.

Authors:  Anika Männer; Dominique Thomas; Marlies Wagner; Jürgen Konczalla; Helmuth Steinmetz; Robert Brunkhorst; Waltraud Pfeilschifter
Journal:  Neurol Res Pract       Date:  2020-11-23

Review 8.  The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines.

Authors:  Bianca C Field; Ruth Gordillo; Philipp E Scherer
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-02       Impact factor: 5.555

9.  Administration of an Acidic Sphingomyelinase (ASMase) Inhibitor, Imipramine, Reduces Hypoglycemia-Induced Hippocampal Neuronal Death.

Authors:  A Ra Kho; Bo Young Choi; Song Hee Lee; Dae Ki Hong; Beom Seok Kang; Si Hyun Lee; Sang Won Suh
Journal:  Cells       Date:  2022-02-14       Impact factor: 6.600

Review 10.  Lipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways.

Authors:  Vidyani Suryadevara; Ramaswamy Ramchandran; David W Kamp; Viswanathan Natarajan
Journal:  Int J Mol Sci       Date:  2020-06-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.